Navigation Links
inVentiv Health Selected to Provide Sales Operations Support for Santarus
Date:11/14/2011

hich are indicated as adjuncts to diet and exercise to improve glycemic control in adults with type 2 diabetes.

Santarus also has a diverse development pipeline, including three investigational drugs in Phase III clinical programs: UCERIS™ (budesonide) Tablets for induction of remission of active ulcerative colitis, RHUCIN® (recombinant human C1 inhibitor) for treatment of acute attacks of hereditary angioedema and rifamycin SV MMX® for treatment of travelers' diarrhea, in addition to other earlier-stage development programs. More information about Santarus is available at www.santarus.com.

About inVentiv Health

inVentiv Health, Inc. is a leading global provider of best-in-class clinical, commercial and consulting services to companies seeking to accelerate performance. inVentiv's client roster includes more than 550 pharmaceutical, biotech and life sciences companies. With 13,000 employees in 40 countries, inVentiv rapidly transforms promising ideas into commercial reality. inVentiv Health Inc. is privately owned by inVentiv Group Holdings Inc., an organization sponsored by affiliates of Thomas H. Lee Partners, L.P., Liberty Lane Partners and members of the inVentiv management team. For more information, visit http://www.inventivhealth.com.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause inVentiv Health's performance to differ materially. Such risks include, without limitation: the impact of our substantial level of indebtedness on our ability to generate sufficient cash to fulfill our obligations under our existing debt instruments or our ability to incur additional indebtedness; the impact of the consummation of any announced acquisitions, and any additional
'/>"/>

SOURCE inVentiv Health, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. AWAC Becomes inVentiv Medical Management™
2. Ocean Tomo Study Ranks Top 25 Most Inventive Companies for Bloomberg BusinessWeek
3. Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health
4. iSource Networks Partners with inVentiv Health to Develop New Technology Platform for Reaching Healthcare Consumers
5. inVentiv Health to Announce First Quarter 2009 Results and Conduct Conference Call on Friday, May 8
6. Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
7. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
8. Bayer HealthCares Cotavance® Drug Eluting Balloon With Paccocath® Technology Reduced Five-Year Target Lesion Revascularization Rates by 59 Percent in PAD Patients Compared to Those Treated With Uncoated Balloon
9. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
10. Sangamo BioSciences Announces Presentation at the Lazard Capital Markets 8th Annual Healthcare Conference
11. "Tomorrows Health" TV Series Showing the Life Science Industrys Quest to Save and Improve Lives, to Air on Select NBC Stations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... MD (PRWEB) May 17, 2013 ... of ezColony version 4.1, a versatile refinement to ... premier software solution, improves its advanced methodical management ... facilities with ezColony 4.1. The network-based platform provides ... conduct effective research. While continuing to emphasize streamlined ...
(Date:5/16/2013)... 16, 2013 ISPE ... Myers, CAE, to the newly created position of ... role, Myers will be responsible for stimulating ISPE’s ... strategies, advancing the Society’s Member-led and staff-driven business ... to refine organizational, membership and product marketing. , ...
(Date:5/16/2013)... Kitware , a leading provider of ... II SBIR funding from the U.S. Department of ... high performance computing (HPC) simulation and computation framework. ... select only the toolkits and applications needed to ... tasks. , Manufacturers increasingly rely on simulation ...
(Date:5/16/2013)... 16, 2013 On average, developing a ... one billion dollars. Despite this investment, less than 10% ... high, is your clinical trial design optimally structured to ... outcomes? , Dr. Frederic Sax, Global Head of the ... use of data, information and technology in upfront clinical ...
Breaking Biology Technology:RURO Introduces ezColony 4.1 – The Versatile Transgenic Animal Colony Management Software 2ISPE Names Barbara A. Myers, CAE, as Vice President of Professional Development 2Kitware Develops a Customizable Simulation Framework to Provide HPC for Small to Mid-Sized Manufacturers 2Optimizing Clinical Trials Outcomes through Computer Assisted Design, New Life Science Webinar Hosted by Xtalks 2
... available in German . , Carbon nanotubes ... promising candidates for optoelectronic components. However, so far it ... optic and electronic properties. A team of researchers headed ... Universitaet Muenchen and member of the Cluster of Excellence ...
... 7, 2011 Reportlinker.com announces that a ... its catalogue: http://www.reportlinker.com/p0368623/The-2011-Top-Ten-Worlds-Leading-Life-Science-Intermediates-Companies.html ... the competitive environment is widely recognized as ... the task crucial to business survival, growth ...
... Reportlinker.com announces that a new market research report ... Nanobiotechnologies- applications, markets and companies ... the creation and utilization of materials, devices, and ... nanometer-length scale (a nanometer is one billionth of ...
Cached Biology Technology:Ultra fast photodetectors out of carbon nanotubes 2Reportlinker Adds The 2011 Top Ten World's Leading Life Science Intermediates Companies 2Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 2Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 3
(Date:5/15/2013)... trial to date to examine the efficacy of PARP ... than breast and ovarian cancer, the oral drug olaparib ... prostate cancers. Results of the study, led by researchers ... of Pennsylvania and Sheba Medical Center in Tel Hashomer, ... Clinical Oncology,s annual meeting in Chicago in early June ...
(Date:5/15/2013)... N.Y. - Clam fossils from the middle Devonian era ... a better paleontological picture of the capacity of ecosystems ... according to research published today (May 15) in the ... examine species abundance the head counts of specimens ... The research shows that factors such as predation and ...
(Date:5/15/2013)... world-renowned filmmaker James Cameron has been named by Scripps ... recipient of the 2013 Nierenberg Prize for Science in ... his record-setting DEEPSEA CHALLENGE expedition and exploration of the ... on the UC San Diego campus. , In addition, ... and promise of the deep sea has been considerably ...
Breaking Biology News(10 mins):PARP inhibitor shows activity in pancreatic, prostate cancers among patients carrying BRCA mutations 2Clam fossils divulge secrets of ecologic stability 2James Cameron to be publicly honored with Scripps Nierenberg Prize 2James Cameron to be publicly honored with Scripps Nierenberg Prize 3James Cameron to be publicly honored with Scripps Nierenberg Prize 4
... incandescent light bulb in the 19th century spurred on ... extending leisure time and bringing us to the point ... range of devices from mood lighting to audiovisual media ... vacuum cleaners to high-speed broadband connected computers in their ...
... Finland, has been the first in the world to ... in the treatment of osteoarthritis and rheumatoid arthritis. ... that allows the product to be sold in the ... since the mid-1990s, is the result of collaboration between ...
... This release is available in German . ... component of the Lily of the Valley scent known as Bourgeonal alters ... of the Valley phenomenon" also the title of a book about ... act as swimming olfactory cells which follow a "scent trail" laid by ...
Cached Biology News:Developing sustainable power 2Researchers develop world's first biodegradable joint implant 2The end of the 'Lily of the Valley phenomenon' in sperm research? 2The end of the 'Lily of the Valley phenomenon' in sperm research? 3
... a microprocessor controlled, high speed filter ... exceptionally smooth operation make the Lambda ... fluorescence microscopy, ratio imaging, spectrophotometry, visual ... and accurate aperture positioning. The Lambda ...
PTFE/red rubber septum silver aluminum seal ,11 mm seal diam. ...
... enzyme that catalyzes the conversion,of starch ... maltotriose and,dextrins. The level of a-amylase ... are of clinical importance,1-3 while plant ... industry.4, The EnzChek Amylase Assay Kit ...
Rat monoclonal [20d5] to NKG2A + C+ E ( Abpromise for all tested applications). Antigen: Tissue / cell preparation (Mouse): CHO transfected cells expressing the B6 allele of NKG2A. Entrez Gen...
Biology Products: